Loading…

Identification of intracellular targets of small molecular weight chemical compounds using affinity chromatography

Efforts to characterize small molecular weight chemical inhibitors of pharmacological interest tend to identify molecules with high efficiency and selectivity, to meet the two criteria required for the clinical development of a drug: efficacy and harmlessness. Drug candidates are expected to inhibit...

Full description

Saved in:
Bibliographic Details
Published in:Biotechnology journal 2007-01, Vol.2 (1), p.68-75
Main Authors: Guiffant, Damien, Tribouillard, Déborah, Gug, Fabienne, Galons, Hervé, Meijer, Laurent, Blondel, Marc, Bach, Stéphane
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4673-819a3c5a85c7b776d05721996dc28b1a2d9e9cb798a116eadb52c58a86f6d45d3
cites cdi_FETCH-LOGICAL-c4673-819a3c5a85c7b776d05721996dc28b1a2d9e9cb798a116eadb52c58a86f6d45d3
container_end_page 75
container_issue 1
container_start_page 68
container_title Biotechnology journal
container_volume 2
creator Guiffant, Damien
Tribouillard, Déborah
Gug, Fabienne
Galons, Hervé
Meijer, Laurent
Blondel, Marc
Bach, Stéphane
description Efforts to characterize small molecular weight chemical inhibitors of pharmacological interest tend to identify molecules with high efficiency and selectivity, to meet the two criteria required for the clinical development of a drug: efficacy and harmlessness. Drug candidates are expected to inhibit efficiently the target they have been optimized against (for example, a particular type of protein kinase). These hits are also designed to not interfere (or as little as possible) with the activity of other cellular enzymes/proteins to reduce undesired side effects. Here we discuss the use of immobilized drugs as affinity chromatography matrices to purify and identify their bona fide intracellular targets. This method not only allows the systematic investigation of the selectivity of pharmacological compounds but also the anticipation of their putative adverse effects.
doi_str_mv 10.1002/biot.200600223
format article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_00169462v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19772194</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4673-819a3c5a85c7b776d05721996dc28b1a2d9e9cb798a116eadb52c58a86f6d45d3</originalsourceid><addsrcrecordid>eNqFkc1v1DAQxSMEoqVw5YhyQuKQxXbir2OpaHel7cdhEUdr4ji7BidebKdl_3sSslq49TQez-89jeZl2XuMFhgh8rm2Pi0IQmxsSPkiO8eCoYKXuHp5fDPOxFn2JsYfCFW0RNXr7AxzQiih-DwLq8b0ybZWQ7K-z32b2z4F0Ma5wUHIE4StSXEaxA6cyzvvjP47ejJ2u0u53plulLtc-27vh76J-RBtv82hbW1v02Ekgu8g-W2A_e7wNnvVgovm3bFeZN-uv26ulsX6_mZ1dbkudMV4WQgsodQUBNW85pw1iHKCpWSNJqLGQBpppK65FIAxM9DUlGgqQLCWNRVtyovs0-y7A6f2wXYQDsqDVcvLtZr-EMJMVow84pH9OLP74H8NJibV2TjdAHrjh6iYkBUm1fMglnzashrBxQzq4GMMpj2tgJGaolNTdOoU3Sj4cHQe6s40__BjViMgZ-DJOnN4xk59Wd1v_jcvZq2Nyfw-aSH8VOOtOVXf727UQymW_PaWqk35B52StlY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19772194</pqid></control><display><type>article</type><title>Identification of intracellular targets of small molecular weight chemical compounds using affinity chromatography</title><source>Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list)</source><creator>Guiffant, Damien ; Tribouillard, Déborah ; Gug, Fabienne ; Galons, Hervé ; Meijer, Laurent ; Blondel, Marc ; Bach, Stéphane</creator><creatorcontrib>Guiffant, Damien ; Tribouillard, Déborah ; Gug, Fabienne ; Galons, Hervé ; Meijer, Laurent ; Blondel, Marc ; Bach, Stéphane</creatorcontrib><description>Efforts to characterize small molecular weight chemical inhibitors of pharmacological interest tend to identify molecules with high efficiency and selectivity, to meet the two criteria required for the clinical development of a drug: efficacy and harmlessness. Drug candidates are expected to inhibit efficiently the target they have been optimized against (for example, a particular type of protein kinase). These hits are also designed to not interfere (or as little as possible) with the activity of other cellular enzymes/proteins to reduce undesired side effects. Here we discuss the use of immobilized drugs as affinity chromatography matrices to purify and identify their bona fide intracellular targets. This method not only allows the systematic investigation of the selectivity of pharmacological compounds but also the anticipation of their putative adverse effects.</description><identifier>ISSN: 1860-6768</identifier><identifier>EISSN: 1860-7314</identifier><identifier>DOI: 10.1002/biot.200600223</identifier><identifier>PMID: 17225251</identifier><language>eng</language><publisher>Weinheim: WILEY-VCH Verlag</publisher><subject>Affinity chromatography ; Biochemistry, Molecular Biology ; Biopolymers ; Biopolymers - analysis ; Biopolymers - chemistry ; Chromatography, Affinity ; Chromatography, Affinity - methods ; Competition assays ; Drug Design ; Life Sciences ; Microchemistry ; Microchemistry - methods ; Molecular Weight ; Pharmaceutical Preparations ; Pharmaceutical Preparations - chemistry ; Selectivity ; Subcellular Fractions ; Subcellular Fractions - chemistry</subject><ispartof>Biotechnology journal, 2007-01, Vol.2 (1), p.68-75</ispartof><rights>Copyright © 2007 WILEY‐VCH Verlag GmbH &amp; Co. KGaA, Weinheim</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4673-819a3c5a85c7b776d05721996dc28b1a2d9e9cb798a116eadb52c58a86f6d45d3</citedby><cites>FETCH-LOGICAL-c4673-819a3c5a85c7b776d05721996dc28b1a2d9e9cb798a116eadb52c58a86f6d45d3</cites><orcidid>0000-0002-7186-7483 ; 0000-0003-3511-4916 ; 0000-0003-4897-2995</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17225251$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-00169462$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Guiffant, Damien</creatorcontrib><creatorcontrib>Tribouillard, Déborah</creatorcontrib><creatorcontrib>Gug, Fabienne</creatorcontrib><creatorcontrib>Galons, Hervé</creatorcontrib><creatorcontrib>Meijer, Laurent</creatorcontrib><creatorcontrib>Blondel, Marc</creatorcontrib><creatorcontrib>Bach, Stéphane</creatorcontrib><title>Identification of intracellular targets of small molecular weight chemical compounds using affinity chromatography</title><title>Biotechnology journal</title><addtitle>Biotechnology Journal</addtitle><description>Efforts to characterize small molecular weight chemical inhibitors of pharmacological interest tend to identify molecules with high efficiency and selectivity, to meet the two criteria required for the clinical development of a drug: efficacy and harmlessness. Drug candidates are expected to inhibit efficiently the target they have been optimized against (for example, a particular type of protein kinase). These hits are also designed to not interfere (or as little as possible) with the activity of other cellular enzymes/proteins to reduce undesired side effects. Here we discuss the use of immobilized drugs as affinity chromatography matrices to purify and identify their bona fide intracellular targets. This method not only allows the systematic investigation of the selectivity of pharmacological compounds but also the anticipation of their putative adverse effects.</description><subject>Affinity chromatography</subject><subject>Biochemistry, Molecular Biology</subject><subject>Biopolymers</subject><subject>Biopolymers - analysis</subject><subject>Biopolymers - chemistry</subject><subject>Chromatography, Affinity</subject><subject>Chromatography, Affinity - methods</subject><subject>Competition assays</subject><subject>Drug Design</subject><subject>Life Sciences</subject><subject>Microchemistry</subject><subject>Microchemistry - methods</subject><subject>Molecular Weight</subject><subject>Pharmaceutical Preparations</subject><subject>Pharmaceutical Preparations - chemistry</subject><subject>Selectivity</subject><subject>Subcellular Fractions</subject><subject>Subcellular Fractions - chemistry</subject><issn>1860-6768</issn><issn>1860-7314</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqFkc1v1DAQxSMEoqVw5YhyQuKQxXbir2OpaHel7cdhEUdr4ji7BidebKdl_3sSslq49TQez-89jeZl2XuMFhgh8rm2Pi0IQmxsSPkiO8eCoYKXuHp5fDPOxFn2JsYfCFW0RNXr7AxzQiih-DwLq8b0ybZWQ7K-z32b2z4F0Ma5wUHIE4StSXEaxA6cyzvvjP47ejJ2u0u53plulLtc-27vh76J-RBtv82hbW1v02Ekgu8g-W2A_e7wNnvVgovm3bFeZN-uv26ulsX6_mZ1dbkudMV4WQgsodQUBNW85pw1iHKCpWSNJqLGQBpppK65FIAxM9DUlGgqQLCWNRVtyovs0-y7A6f2wXYQDsqDVcvLtZr-EMJMVow84pH9OLP74H8NJibV2TjdAHrjh6iYkBUm1fMglnzashrBxQzq4GMMpj2tgJGaolNTdOoU3Sj4cHQe6s40__BjViMgZ-DJOnN4xk59Wd1v_jcvZq2Nyfw-aSH8VOOtOVXf727UQymW_PaWqk35B52StlY</recordid><startdate>200701</startdate><enddate>200701</enddate><creator>Guiffant, Damien</creator><creator>Tribouillard, Déborah</creator><creator>Gug, Fabienne</creator><creator>Galons, Hervé</creator><creator>Meijer, Laurent</creator><creator>Blondel, Marc</creator><creator>Bach, Stéphane</creator><general>WILEY-VCH Verlag</general><general>WILEY‐VCH Verlag</general><general>Wiley-VCH Verlag</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0002-7186-7483</orcidid><orcidid>https://orcid.org/0000-0003-3511-4916</orcidid><orcidid>https://orcid.org/0000-0003-4897-2995</orcidid></search><sort><creationdate>200701</creationdate><title>Identification of intracellular targets of small molecular weight chemical compounds using affinity chromatography</title><author>Guiffant, Damien ; Tribouillard, Déborah ; Gug, Fabienne ; Galons, Hervé ; Meijer, Laurent ; Blondel, Marc ; Bach, Stéphane</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4673-819a3c5a85c7b776d05721996dc28b1a2d9e9cb798a116eadb52c58a86f6d45d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Affinity chromatography</topic><topic>Biochemistry, Molecular Biology</topic><topic>Biopolymers</topic><topic>Biopolymers - analysis</topic><topic>Biopolymers - chemistry</topic><topic>Chromatography, Affinity</topic><topic>Chromatography, Affinity - methods</topic><topic>Competition assays</topic><topic>Drug Design</topic><topic>Life Sciences</topic><topic>Microchemistry</topic><topic>Microchemistry - methods</topic><topic>Molecular Weight</topic><topic>Pharmaceutical Preparations</topic><topic>Pharmaceutical Preparations - chemistry</topic><topic>Selectivity</topic><topic>Subcellular Fractions</topic><topic>Subcellular Fractions - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Guiffant, Damien</creatorcontrib><creatorcontrib>Tribouillard, Déborah</creatorcontrib><creatorcontrib>Gug, Fabienne</creatorcontrib><creatorcontrib>Galons, Hervé</creatorcontrib><creatorcontrib>Meijer, Laurent</creatorcontrib><creatorcontrib>Blondel, Marc</creatorcontrib><creatorcontrib>Bach, Stéphane</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Biotechnology journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Guiffant, Damien</au><au>Tribouillard, Déborah</au><au>Gug, Fabienne</au><au>Galons, Hervé</au><au>Meijer, Laurent</au><au>Blondel, Marc</au><au>Bach, Stéphane</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identification of intracellular targets of small molecular weight chemical compounds using affinity chromatography</atitle><jtitle>Biotechnology journal</jtitle><addtitle>Biotechnology Journal</addtitle><date>2007-01</date><risdate>2007</risdate><volume>2</volume><issue>1</issue><spage>68</spage><epage>75</epage><pages>68-75</pages><issn>1860-6768</issn><eissn>1860-7314</eissn><abstract>Efforts to characterize small molecular weight chemical inhibitors of pharmacological interest tend to identify molecules with high efficiency and selectivity, to meet the two criteria required for the clinical development of a drug: efficacy and harmlessness. Drug candidates are expected to inhibit efficiently the target they have been optimized against (for example, a particular type of protein kinase). These hits are also designed to not interfere (or as little as possible) with the activity of other cellular enzymes/proteins to reduce undesired side effects. Here we discuss the use of immobilized drugs as affinity chromatography matrices to purify and identify their bona fide intracellular targets. This method not only allows the systematic investigation of the selectivity of pharmacological compounds but also the anticipation of their putative adverse effects.</abstract><cop>Weinheim</cop><pub>WILEY-VCH Verlag</pub><pmid>17225251</pmid><doi>10.1002/biot.200600223</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-7186-7483</orcidid><orcidid>https://orcid.org/0000-0003-3511-4916</orcidid><orcidid>https://orcid.org/0000-0003-4897-2995</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1860-6768
ispartof Biotechnology journal, 2007-01, Vol.2 (1), p.68-75
issn 1860-6768
1860-7314
language eng
recordid cdi_hal_primary_oai_HAL_hal_00169462v1
source Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list)
subjects Affinity chromatography
Biochemistry, Molecular Biology
Biopolymers
Biopolymers - analysis
Biopolymers - chemistry
Chromatography, Affinity
Chromatography, Affinity - methods
Competition assays
Drug Design
Life Sciences
Microchemistry
Microchemistry - methods
Molecular Weight
Pharmaceutical Preparations
Pharmaceutical Preparations - chemistry
Selectivity
Subcellular Fractions
Subcellular Fractions - chemistry
title Identification of intracellular targets of small molecular weight chemical compounds using affinity chromatography
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T09%3A47%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identification%20of%20intracellular%20targets%20of%20small%20molecular%20weight%20chemical%20compounds%20using%20affinity%20chromatography&rft.jtitle=Biotechnology%20journal&rft.au=Guiffant,%20Damien&rft.date=2007-01&rft.volume=2&rft.issue=1&rft.spage=68&rft.epage=75&rft.pages=68-75&rft.issn=1860-6768&rft.eissn=1860-7314&rft_id=info:doi/10.1002/biot.200600223&rft_dat=%3Cproquest_hal_p%3E19772194%3C/proquest_hal_p%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4673-819a3c5a85c7b776d05721996dc28b1a2d9e9cb798a116eadb52c58a86f6d45d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=19772194&rft_id=info:pmid/17225251&rfr_iscdi=true